Nagase & Co., Ltd. · TSE:8012

Nagase & — Q2 FY2026 Earnings Presentation

39 slides from Nagase &'s earnings presentation, Nov 6, 2026

  1. Slide 1: FY2026 Second Quarter Financial Briefing

    FY2026 Second Quarter Financial Briefing NAGASE&CO.,LTD. Stock exchange listing : Tokyo (Prime Market) Code number : 8012 November 6, 2026 Copyright © 2026 NAGASE & CO., LTD.

  2. Slide 2: Executive Summary

    Executive Summary The Company posted record-high net sales and profits at all levels. The Materials segment saw an increase in profit due to soaring market prices caused by the situation in the Middle FY2026 East and the procurement of substitute products to maintain the supply chain, among other fa

  3. Slide 3: Business Environment Surrounding NAGASE Segments

    Business Environment Surrounding NAGASE Segments Industry Full-Year FY2026 Initial Forecast First Half Trends Second Half Trends Segment Although demand for electronic components Electrical and Demand and resin market conditions Demand expected to decline compared to the is rising, overall demand re

  4. Slide 4: Contents

    Contents ■ FY2026 Second Quarter Results and FY2026 Earnings Projections P5~18 ■ TOPICS P19~26 <Appendix> Gross Profit by Region P29 Gross Profit by Business & Segment : Two-Year Comparison P30 Operating Income by Business & Segment : Two-Year Comparison P31 Sales, Gross Profit, and Operating Income

  5. Slide 5: FY2026 Second Quarter Results and FY2026 Earnings Projections

    FY2026 Second Quarter Results and FY2026 Earnings Projections ■ Consolidated Statements of Income P6 ■ Operating Income by Segment : Two-Year Comparison P7 ■ Segment Overview P8~P10 ■ Second Quarter(Jul–Sep):Two-Year Comparison P11 ■ Consolidated Balance Sheets P12 ■ Consolidated Cash Flows P13 ■ FY

  6. Slide 6: Consolidated Statements of Income

    Consolidated Statements of Income ▶ Posted record-high net sales and profits at all levels for any second quarter. ▶ Gross profit increased due to strong performance in the semiconductor business and the Prinova Group, as well as our ability to meet customer demands reliably amid supply chain disrup

  7. Slide 7: Operating Income by Segment: Two-Year Comparison

    Operating Income by Segment : Two-Year Comparison ▶ Profit increased year on year across all segments. Operating Income by Segment (100 millions of yen) Change in Operating Income By Segment (100 millions of yen) 400 Total 363 350 22 363 29 300 Materials 160 41 250 58 Total 210 200 Materials 210 150

  8. Slide 8: Segment Overview: Materials

    Materials Segment Overview: Materials ▶ Gross profit rose ¥8.6 billion year on year. Operating income increased ¥5.8 billion year on year. <Manufacturing> ・ Sales of industrial hoses and civil engineering pipes increased in Nagase RooTAC Industries, Inc. ・ Increased sales of Nagase ChemteX’s epichlo

  9. Slide 9: Segment Overview: Electronics

    Electronics Segment Overview: Electronics ▶ Gross profit rose ¥5.2 billion year on year. Operating income increased ¥4.1 billion year on year. <Manufacturing> ・ Nagase ChemteX saw an increase in sales of formulated epoxy resins. The company steadily captured demand for products for AI semiconductors

  10. Slide 10: Segment Overview: Life Sciences

    Life Sciences Segment Overview: Life Sciences ▶ Gross profit increased ¥8.6 billion year on year. Operating income increased ¥2.9 billion year on year. <Manufacturing> ・ The Prinova Group's manufacturing business saw a significant increase in profits, driven by rising sales in the Solutions business

  11. Slide 11: Second Quarter (Jul–Sep): Two-Year Comparison

    Second Quarter(Jul–Sep):Two-Year Comparison 100 millions of yen Total Materials Electronics Life Sciences FY2025 FY2026 FY2025 FY2026 FY2025 FY2026 FY2025 FY2026 2Q 2Q Change Ratio 2Q 2Q Change Ratio 2Q 2Q Change Ratio 2Q 2Q Change Ratio Jul–Sep Jul–Sep Jul–Sep Jul–Sep Jul–Sep Jul–Sep Jul–Sep Jul–Se

  12. Slide 12: Consolidated Balance Sheets

    Consolidated Balance Sheets ▶ Current assets increased. The increase was due to higher trade accounts receivable and inventories in connection with business growth. ▶ Non-current assets increased. The increase was due to an increase in the market value of investment securities and business investmen

  13. Slide 13: Consolidated Cash Flows

    Consolidated Cash Flows ▶ Net cash used in Operating CF amounted to ¥20.8 billion. Despite profit before tax of ¥43.3 billion, cash flow was impacted by a ¥52.9 billion increase in working capital and ¥8.9 billion in income taxes paid, among other factors. ▶ Net cash used in Investing CF amounted to

  14. Slide 14: FY2026 Earnings Projections (Updated)

    FY2026 Earnings Projections (Updated) ▶ We revised our full-year earnings forecast upward, taking into account second-quarter results and trends expected for the third quarter onward. ▶ We expect to post record-high sales and profits at all levels. ▶ Factors behind these revisions include soaring ma

  15. Slide 15: FY2026 Earnings Projections by Segment (Updated)

    FY2026 Earnings Projections by Segment (Updated) 100 millions of yen Ref. ① ② ②-① FY2026 FY2026 FY2025 Forecast Forecast Change Ratio Actual Released in Released in May 7, 2026 November 6, 2026 Sales 9,727 10,000 10,850 850 8.5% Gross profit 1,876 1,980 2,150 170 8.6% <profit ratio> 19.3% 19.8% 19.8

  16. Slide 16: Gross Profit by Segment and Business

    Gross Profit by Segment and Business ▶ The share of the semiconductor business within the Electronics segment increased. Materials Electronics Life Sciences Gross Profit by Business Gross Profit by Business Gross Profit by Business (100 millions of yen) (100 millions of yen) (100 millions of yen) CA

  17. Slide 17: Shareholder Returns

    Shareholder Returns ▶ We plan to raise the annual dividend per share by ¥3, from the initially planned ¥27 (interim ¥13; year-end ¥14) to ¥30 (interim ¥15; year-end ¥15), marking an expected 17th consecutive year of dividend increases ▶ In November 2026, we resolved to conduct ¥3.0 billion in share

  18. Slide 18: EPS Trend

    EPS Trend ▶ FY2026 EPS expected at ¥118.2, up 50% from FY2025 ▶ With the Medium-Term Management Plan target of 30% growth over three years expected to be achieved, the target will be updated in May 2027 based on the full-year results. 10-Year EPS Trend EPS Expected to EPS(¥) Grow 50% 130 incl. gains

  19. Slide 19: TOPICS

    TOPICS ■ Semiconductor Business Growth: Encapsulants for Advanced Semiconductors (LMC & a-SMC) P20 ■ Prinova Group Business Improvement P21 ■ Accelerating the Development of New Materials: New Biotechnology Research Institute in San Diego, U.S.A. P22 ■ Nagase Food Solutions Co., Ltd. Launched P23 ■

  20. Slide 20: Semiconductor Business Growth: Encapsulants for Advanced Semiconductors (LMC & a-SMC)

    Electronics Semiconductor Business Growth: Encapsulants for Advanced Semiconductors (LMC & a-SMC) ▶ Our business for advanced semiconductors is pursuing sheet-type molding compound a-SMC for high-performance IC package substrates, expecting this product to be a second earnings pillar alongside LMC,

  21. Slide 21: Prinova Group Business Improvement

    Life Sciences Prinova Group Business Improvement ▶ In addition to restoring profitability in Nutrition, we sold the U.S. Flavors business, improving Prinova's earnings and capital efficiency Prinova Nutrition: Performance Improvement 1 (Return to Profitability) 4 Prinova Group: Financial Performance

  22. Slide 22: Accelerating the Development of New Materials: New Biotechnology Research Institute in San Diego

    Life Sciences Accelerating the Development of New Materials: New Biotechnology Research Institute in San Diego, U.S.A. ▶ Dramatically accelerating research-driven development of new materials by leveraging cutting-edge AI and robotics IFC Biotechnology Innovation Center (IBIC), Opened in January 202

  23. Slide 23: Nagase Food Solutions Co., Ltd. Launched

    Life Sciences Nagase Food Solutions Co., Ltd. Launched ▶ Integration of the three companies’ food sales businesses into a unified business structure in July 2026 ▶ One-stop solutions beyond raw materials: material selection, application proposals, and formulation design. Food Ingredients Div. Food S

  24. Slide 24: Continuation and Expansion of CVC Activities: Decision to Establish a Second Fund

    Continuation and Expansion of CVC Activities: Decision to Establish a Second Fund ▶ Building on the track record of the first fund, we plan to accelerate the acquisition of capabilities in new fields and technologies ▶ We decided to establish a second fund and plan to increase the proportion of over

  25. Slide 25: Restructuring or Improvement of Unprofitable Businesses

    Restructuring or Improvement of Unprofitable Businesses ▶ Under the previous medium-term management plan, ACE 2.0, we reduced losses by withdrawing from businesses and transactions that held no prospects for improvement and relinquishing sales rights ▶ We expect to complete the withdrawal from the t

  26. Slide 26: Greater China and ASEAN Regional Headquarters Established

    Greater China and ASEAN Regional Headquarters Established ▶ Appoint executives of Nagase & Co., Ltd. as part-time directors of the new company to enhance board effectiveness. ▶ Accelerate Group-wide transformation to overseas: build a foundation for reform, reshape the organization and shift mindset

  27. Slide 27: Management Philosophy

    Management Philosophy We recognize our responsibility to society and offer beneficial products and services while maintaining the highest standards of integrity. Through our growth, we will contribute to society and enrich the lives of our employees. 27

  28. Slide 28: IR Materials and Inquiries

    ■IR Materials for the first meeting: https://www.nagase.co.jp/english/ir/library/pdf/factbooks/20260826-1.pdf ■NAGASE Group Investor Relations Website: https://www.nagase.co.jp/english/ir/ ■Inquiries: https://www.nagase.co.jp/english/contact/ir/ These presentation materials contain projections based

  29. Slide 29: Gross Profit by Region

    Appendix Gross Profit by Region Domestic & Overseas Gross Profit(100 millions of yen) Overseas Gross Profit by Region(100 millions of yen) 1,200 100.0% Total 1,134 700 Other 1,100 Overseas 9 90.0% Total 626 1.4% 626 1,000 600 80.0% Europe Total 909 102 16.4% 900 Other Overseas Overseas 9 1.9% 70.0%

  30. Slide 30: Gross Profit by Business & Segment: Two-Year Comparison

    Appendix Gross Profit by Business & Segment : Two-Year Comparison Gross Profit By Business & Segment (100 millions of yen) Change in Gross Profit By Segment (100 millions of yen) 1,200 Total 1,134 Total 1,134 (0) 86 1,134 52 86 909 1,000 Manufac Total 909 Total 909 turing Materials 424 457 800 Manuf

  31. Slide 31: Operating Income by Business & Segment: Two-Year Comparison

    Appendix Operating Income by Business & Segment : Two-Year Comparison Operating Income By Business & Segment Change in Operating Income By Segment (100 millions of yen) (100 millions of yen) 400 22 363 Total 363 29 370 Total 363 41 58 340 210 310 Manufacturing 138 37.2% Materials 280 160 250 Materia

  32. Slide 32: Sales, Gross Profit, and Operating Income by Quarter

    Appendix Sales, Gross Profit, and Operating Income by Quarter 100 millions of yen Quarterly results 1Q 2Q YTD vs.PY Sales FY2026 2,797 2,928 5,725 119% FY2025 2,373 2,424 4,797 Change 424 504 928 Gross profit FY2026 551 582 1,134 125% FY2025 443 465 909 Change 108 117 225 <profit ratio> FY2026 19.7%

  33. Slide 33: Segment Overview: Materials

    Materials Appendix Segment Overview: Materials 100 millions of yen FY2026 Forecast Achieve Quarterly results (Released in Gross Profit by ment November 2026) Business FY2025 (100 millions of yen) 1Q 2Q 3Q 4Q YTD Actual Sales FY2026 1,403 1,502 2,905 5,250 55% 815 FY2025 1,189 1,240 1,239 1,236 2,429

  34. Slide 34: Segment Overview: Electronics

    Electronics Appendix Segment Overview: Electronics 100 millions of yen FY2026 Forecast (Released Achieve Quarterly results in ment November Gross Profit by Business 2026) (100 millions of yen) FY2025 1Q 2Q 3Q 4Q YTD Actual Sales FY2026 491 517 1,009 2,000 50% 540 FY2025 415 431 442 439 846 1,728 Dis

  35. Slide 35: Segment Overview: Life Sciences

    Life Sciences Appendix Segment Overview: Life Sciences 100 millions of yen FY2026 Forecast Achieve Quarterly results (Released in November ment 2026) Gross Profit by FY2025 Business 1Q 2Q 3Q 4Q YTD Actual (100 millions of yen) Sales FY2026 902 908 1,810 3,600 50% FY2025 768 751 760 810 1,520 3,092 7

  36. Slide 36: FY2026 Earnings Projections by Major Manufacturing Subsidiaries (Revised)

    FY2026 Earnings Projections by Major Manufacturing Subsidiaries (Revised) 100 millions of yen Ref. ① ② ②-① FY2026 FY2026 FY2025 Forecast Forecast Change Ratio Actual Released in Released in May 7, 2026 November 6, 2026 Sales 425 423 546 123 29% ● In the first half, sales of formulated epoxy resins f

  37. Slide 37: Overview of Major Manufacturing Subsidiaries: Nagase ChemteX Group

    Appendix Overview of Major Manufacturing Subsidiaries: Nagase ChemteX Group ▶ Gross profit increased by ¥3.8 billion year on year. Operating income increased by ¥2.9 billion year on year. ・ Operating profit from modified epoxy resin products increased overall, driven by higher sales of LMC for AI se

  38. Slide 38: Overview of Major Manufacturing Subsidiaries: Nagase Viita

    Appendix Overview of Major Manufacturing Subsidiaries: Nagase Viita ▶ Gross profit and operating income were level with the previous fiscal year. ・ Operating income declined for food ingredients sales. While sales volume was level year on year, rising raw materials prices had a negative impact on re

  39. Slide 39: Overview of Major Manufacturing Subsidiaries: Prinova Group

    Appendix Overview of Major Manufacturing Subsidiaries: Prinova Group ▶ Gross profit increased by ¥6.4 billion year on year. Operating income increased by ¥2.6 billion year on year. ・ Operating profit in the manufacturing business increased, driven by higher sales in the Solutions business due to exp

Nagase & — Q2 FY2026 Earnings Presentation on 6ix